Christopher Francis
Corporate Officer/Principal at WAVE LIFE SCIENCES LTD.
Net worth: 377 844 $ as of 29/04/2024
Network origin in Christopher Francis first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.
30
| Subsidiary | Pharmaceuticals: Major | 30 |
| Public Company | Biotechnology | 29 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher Francis via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Director/Board Member Director/Board Member Director/Board Member Founder Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Founder Corporate Officer/Principal Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
Wave Life Sciences UK Ltd.
 Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Wave Life Sciences Ltd., Wave Life Sciences UK Ltd. is a pharmaceutical company founded in 2017. The company is based in Birmingham, UK and specializes in manufacturing pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director of Finance/CFO Chief Operating Officer | |
| VERASTEM, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
| RESEARCH ALLIANCE CORP. II | Financial Conglomerates | Chief Executive Officer Director of Finance/CFO | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Founder Corporate Officer/Principal | |
| University of Rhode Island | College/University | Doctorate Degree Doctorate Degree | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member President | |
Calimmune, Inc.
 Calimmune, Inc. BiotechnologyHealth Technology Calimmune, Inc. operates as a clinical-stage biotechnology company. The firm offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. The company was founded by David Baltimore, Inder M. Verma, Irvin Chen and Louis Breton in 2006 and is headquartered in Tucson, AZ. | Biotechnology | Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree | |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Undergraduate Degree Doctorate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Private Equity Investor Private Equity Investor | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal General Counsel | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OxOnc Development LP
 OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Toronto | College/University | Doctorate Degree Undergraduate Degree | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| University of Tokyo | College/University | Undergraduate Degree Graduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
| SATSUMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Mitsubishi Corporation LT USA
 Mitsubishi Corporation LT USA Wholesale DistributorsDistribution Services Part of Mitsubishi Corp., Mitsubishi Corporation LT USA is a company that engages in the distribution of electronics, fuels, metals, and chemicals. The company is based in Schaumburg, IL. | Wholesale Distributors | Corporate Officer/Principal | |
Incyclix Bio LLC
 Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| Western Carolina University | College/University | Undergraduate Degree | |
| Wake Forest University | College/University | Doctorate Degree | |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
Aravax Pty Ltd.
 Aravax Pty Ltd. BiotechnologyHealth Technology Aravax Pty Ltd. develops treatments for peanut allergies. The company was founded in May 2015 and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 44 |
| United Kingdom | 3 |
| Cayman Islands | 2 |
| Switzerland | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 14 |
| Finance | 7 |
| Utilities | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 215 |
| Corporate Officer/Principal | 160 |
| Independent Dir/Board Member | 65 |
| Chief Tech/Sci/R&D Officer | 50 |
| Undergraduate Degree | 48 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Alexander Ingram | 43 |
| Peter Kolchinsky | 32 |
| Mark Corrigan | 29 |
| Gregory Verdine | 25 |
| David H. Donabedian | 24 |
| Michelle Dipp | 22 |
| Debasish Francois Roychowdhury | 18 |
| Christian Henry | 17 |
| Barbara Weber | 16 |
| June Almenoff | 14 |
| Anne Phillips | 14 |
| Ken Takanashi | 13 |
| Matthew Foehr | 13 |
| Curran Simpson | 12 |
| Takeshi Wada | 12 |
- Stock Market
- Insiders
- Christopher Francis
- Company connections